Flow Forward Medical raises additional $1.3M
May 18, 2015 | Bobby Burch
Flow Forward Medical boosted its latest funding round to further develop its device that helps improve outcomes for hemodialysis patients.
The Olathe-based company closed a $1.3 million round of additional Series A financing led by the Kansas Bioscience Authority. Flow Forward previously raised $4.4 million, bringing its total funding raised to date to about $5.7 million.
Flow Forward created the AFE blood pump system, which is designed for temporary use to quickly dilate peripheral veins through flow-mediated vascular remodeling prior to arteriovenous fistula surgery. In addition to mitigating care costs, the device reduces morbidity and mortality in hemodialysis patients.
Flow Forward also announced that it will receive a $225,000 Phase I Small Business Innovation Research grant from the National Institutes of Health. The grant will help fund testing on peripheral vein dilation with the AFE System prior to AVF creation in a nonclinical model.
Flow Forward is a spinoff of CEO Nick Franano’s previous company, Novita Therapeutics. To learn more on Flow Forward and its device, click here.
Featured Business
2015 Startups to Watch
stats here
Related Posts on Startland News
HEMP brings Apple co-founder to KC as featured speaker
Steve Wozniak, co-founder of Apple, will be the keynote speaker at The Helzberg Entrepreneurial Mentoring Program’s 20th anniversary celebration. Wozniak’s experience shaping the computing industry and influential product design for Apple have produced him fame as one of technology’s key thought leaders. “As a successful entrepreneur, Steve Wozniak understands the importance a mentor can make…
In time for Mother’s Day: Ovatemp wants to boost women’s fertility
The arrival of Ana Mayer’s baby girl isn’t the only thing she’ll be thinking about this Mother’s Day. Mayer — who’s among the newest founders in the Techstars-led Sprint Mobile Health Accelerator in Kansas City — will also be mulling how to further develop Ovatemp, the Boston-based ovulation tech company she leads. Ovatemp offers women…
Founder of defunct Symptomly shares lessons from failure
Failure is a touchy subject. But for Derek Bereit — the former CEO and co-founder of mobile asthma tracking company Symptomly — his company’s failure was an opportunity shrouded in a difficult situation. Rather than sulking, Bereit sat down with Startland News to discuss Symptomly’s demise, the lessons it provided him and the possibilities that…